新闻/Reuters/Merus’ Petosemtamab With Pembrolizumab Interim Data Demonstrates Robust Efficacy And Durability In 1L Pd-L1+ R/M HnsccMerus’ Petosemtamab With Pembrolizumab Interim Data Demonstrates Robust Efficacy And Durability In 1L Pd-L1+ R/M HnsccRefinitiv阅读少于1分钟MRUSMerus NV MRUS:MERUS’ PETOSEMTAMAB WITH PEMBROLIZUMAB INTERIM DATA DEMONSTRATES ROBUST EFFICACY AND DURABILITY IN 1L PD-L1+ R/M HNSCCReuters欧洲© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
